|
1
|
Menna P, Recalcati S, Cairo G and Minotti
G: An introduction to the metabolic determinants of anthracycline
cardiotoxicity. Cardiovasc Toxicol. 7:80–85. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lipshultz SE, Karnik R, Sambatakos P,
Franco VI, Ross SW and Miller TL: Anthracycline-related
cardiotoxicity in childhood cancer survivors. Curr Opin Cardiol.
29:103–112. 2014. View Article : Google Scholar
|
|
3
|
Spallarossa P, Garibaldi S, Altieri P,
Fabbi P, Manca V, Nasti S, Rossettin P, Ghigliotti G, Ballestrero
A, Patrone F, et al: Carvedilol prevents doxorubicin-induced free
radical release and apoptosis in cardiomyocytes in vitro. J Mol
Cell Cardiol. 37:837–846. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Raturi A, Ortiz-Sandoval C and Simmen T:
Redox dependence of endoplasmic reticulum (ER) Ca2+
signaling. Histol Histopathol. 29:543–552. 2014.
|
|
5
|
Ma J and Pan Z: Retrograde activation of
store-operated calcium channel. Cell Calcium. 33:375–384. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mesaeli N, Nakamura K, Zvaritch E, Dickie
P, Dziak E, Krause KH, Opas M, MacLennan DH and Michalak M:
Calreticulin is essential for cardiac development. J Cell Biol.
144:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Milan D, Griffith J, Su M, Price ER and
McKeon F: The latch region of calcineurin B is involved in both
immunosuppressant-immunophilin complex docking and phosphatase
activation. Cell. 79:437–447. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nakamura K, Robertson M, Liu G, Dickie P,
Guo JQ, Duff HJ, Opas M, Kavanagh K and Michalak M: Complete heart
block and sudden death in mice overexpressing calreticulin. J Clin
Invest. 107:1245–1253. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lynch JM, Chilibeck K, Qui Y and Michalak
M: Assembling pieces of the cardiac puzzle; calreticulin and
calcium-dependent pathways in cardiac development, health and
disease. Trends Cardiovasc Med. 16:65–69. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kageyama K, Ihara Y, Goto S, Urata Y, Toda
G, Yano K and Kondo T: Overexpression of calreticulin modulates
protein kinase B/Akt signaling to promote apoptosis during cardiac
differentiation of cardiomyoblast H9c2 cells. J Biol Chem.
277:19255–19264. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ihara Y, Urata Y, Goto S and Kondo T: Role
of calreticulin in the sensitivity of myocardiac H9c2 cells to
oxidative stress caused by hydrogen peroxide. Am J Physiol Cell
Physiol. 290:C208–C221. 2006. View Article : Google Scholar
|
|
12
|
Konishi M, Haraguchi G, Ohigashi H,
Ishihara T, Saito K, Nakano Y and Isobe M: Adiponectin protects
against doxorubicin-induced cardiomyopathy by anti-apoptotic
effects through AMPK up-regulation. Cardiovasc Res. 89:309–319.
2011. View Article : Google Scholar
|
|
13
|
Zhang Y, Tang ZH, Ren Z, Qu SL, Liu MH,
Liu LS and Jiang ZS: Hydrogen sulfide, the next potent preventive
and therapeutic agent in aging and age-associated diseases. Mol
Cell Biol. 33:1104–1113. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Huang YE, Tang ZH, Xie W, Shen XT, Liu MH,
Peng XP, Zhao ZZ, Nie DB, Liu LS and Jiang ZS: Endogenous hydrogen
sulfide mediates the cardioprotection induced by ischemic
post-conditioning in the early reperfusion phase. Exp Ther Med.
4:1117–1123. 2012.PubMed/NCBI
|
|
15
|
Guo R, Lin J, Xu W, Shen N, Mo L, Zhang C
and Feng J: Hydrogen sulfide attenuates doxorubicin-induced
cardiotoxicity by inhibition of the p38 MAPK pathway in H9c2 cells.
Int J Mol Med. 31:644–650. 2013.PubMed/NCBI
|
|
16
|
Kimura H: Hydrogen sulfide: Its
production, release and functions. Amino Acids. 41:113–121. 2011.
View Article : Google Scholar
|
|
17
|
Wang X, Wang XL, Chen HL, Wu D, Chen JX,
Wang XX, Li RL, He JH, Mo L, Cen X, et al: Ghrelin inhibits
doxorubicin cardiotoxicity by inhibiting excessive autophagy
through AMPK and p38-MAPK. Biochem Pharmacol. 88:334–350. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Guo R, Wu K, Chen J, Mo L, Hua X, Zheng D,
Chen P, Chen G, Xu W and Feng J: Exogenous hydrogen sulfide
protects against doxorubicin-induced inflammation and cytotoxicity
by inhibiting p38MAPK/NFκB pathway in H9c2 cardiac cells. Cell
Physiol Biochem. 32:1668–1680. 2013.
|
|
19
|
Ji Y, Pang QF, Xu G, Wang L, Wang JK and
Zeng YM: Exogenous hydrogen sulfide postconditioning protects
isolated rat hearts against ischemia-reperfusion injury. Eur J
Pharmacol. 587:1–7. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Osipov RM, Robich MP, Feng J, Liu Y,
Clements RT, Glazer HP, Sodha NR, Szabo C, Bianchi C and Sellke FW:
Effect of hydrogen sulfide in a porcine model of myocardial
ischemia-reperfusion: Comparison of different administration
regimens and characterization of the cellular mechanisms of
protection. J Cardiovasc Pharmacol. 54:287–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sodha NR, Clements RT, Feng J, Liu Y,
Bianchi C, Horvath EM, Szabo C and Sellke FW: The effects of
therapeutic sulfide on myocardial apoptosis in response to
ischemia-reperfusion injury. Eur J Cardiothorac Surg. 33:906–913.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pan TT, Feng ZN, Lee SW, Moore PK and Bian
JS: Endogenous hydrogen sulfide contributes to the cardioprotection
by metabolic inhibition preconditioning in the rat ventricular
myocytes. J Mol Cell Cardiol. 40:119–130. 2006. View Article : Google Scholar
|
|
23
|
Bian JS, Yong QC, Pan TT, Feng ZN, Ali MY,
Zhou S and Moore PK: Role of hydrogen sulfide in the
cardioprotection caused by ischemic preconditioning in the rat
heart and cardiac myocytes. J Pharmacol Exp Ther. 316:670–678.
2006. View Article : Google Scholar
|
|
24
|
Michalak M, Lynch J, Groenendyk J, Guo L,
Robert Parker JM and Opas M: Calreticulin in cardiac development
and pathology. Biochim Biophys Acta. 1600:32–37. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Coe H and Michalak M: Calcium binding
chaperones of the endoplasmic reticulum. Gen Physiol Biophys.
28:F96–F103. 2009.
|
|
26
|
Rauch F, Prud'homme J, Arabian A, Dedhar S
and St-Arnaud R: Heart, brain and body wall defects in mice lacking
calreticulin. Exp Cell Res. 256:105–111. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Nakamura K, Bossy-Wetzel E, Burns K, Fadel
MP, Lozyk M, Goping IS, Opas M, Bleackley RC, Green DR and Michalak
M: Changes in endoplasmic reticulum luminal environment affect cell
sensitivity to apoptosis. J Cell Biol. 150:731–740. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schwarzer M, Osterholt M, Lunkenbein A,
Schrepper A, Amorim P and Doenst T: Mitochondrial reactive oxygen
species production and respiratory complex activity in rats with
pressure overload-induced heart failure. J Physiol. 592:3767–3782.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Matsushima S, Ide T, Yamato M, Matsusaka
H, Hattori F, Ikeuchi M, Kubota T, Sunagawa K, Hasegawa Y, Kurihara
T, et al: Overexpression of mitochondrial peroxiredoxin-3 prevents
left ventricular remodeling and failure after myocardial infarction
in mice. Circulation. 113:1779–1786. 2006. View Article : Google Scholar : PubMed/NCBI
|
